Literature DB >> 28150197

Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.

Amber A McBride1, Dominique N Price2, Pavan Muttil3.   

Abstract

The purpose of this chapter is to detail the formulation and characterization of a magnetically-targeted drug delivery vehicle, termed nano-in-microparticles (NIMs), for pulmonary drug delivery. Currently, chemotherapeutics and antibiotics are delivered systemically and result in whole body side-effects. NIMs are formulated with superparamagnetic iron oxide nanoparticles, termed SPIONs, making these particles targetable to specific lung regions using a strong external magnet. Additionally, these particles can be formulated to contain any drug or therapeutic agent, such that a therapeutic dose can be delivered to a specific tissue location using the SPIONs-magnet interaction. Finally, these particles are in the appropriate size range for pulmonary delivery, making NIMs therapeutics feasibly inhalable.To generate these particles a solution containing lactose, SPIONs, and a microsphere dye (used as a drug surrogate) is spray-dried using a laboratory-scale spray dryer. The resulting dry powder microparticles (NIMs) can be characterized for their size and morphological properties by various techniques that are presented in this chapter.The utility of NIMs as a magnetic field-dependent targeting delivery platform in an in vivo mouse model has been demonstrated, and a protocol detailing the intratracheal delivery of NIMs dry powder is included as a separate chapter in this book.

Entities:  

Keywords:  Dry powders; Iron oxide nanoparticles; Nano-in-microparticles; Pulmonary delivery; Spray drying

Mesh:

Substances:

Year:  2017        PMID: 28150197      PMCID: PMC7519879          DOI: 10.1007/978-1-4939-6646-2_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  In vitro and in vivo lung deposition of coated magnetic aerosol particles.

Authors:  Yuanyuan Xie; P Worth Longest; Yun Hao Xu; Jian Ping Wang; Timothy Scott Wiedmann
Journal:  J Pharm Sci       Date:  2010-11       Impact factor: 3.534

2.  Biodegradable microparticles as controlled release antigen delivery systems.

Authors:  D T O'Hagan; D Rahman; J P McGee; H Jeffery; M C Davies; P Williams; S S Davis; S J Challacombe
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

Review 3.  Dry powder inhaler formulation.

Authors:  Martin J Telko; Anthony J Hickey
Journal:  Respir Care       Date:  2005-09       Impact factor: 2.258

Review 4.  Spray drying technique. I: Hardware and process parameters.

Authors:  Krzysztof Cal; Krzysztof Sollohub
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

5.  A new respirable form of rifampicin.

Authors:  Yoen-Ju Son; Jason T McConville
Journal:  Eur J Pharm Biopharm       Date:  2011-02-13       Impact factor: 5.571

6.  Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.

Authors:  Gregory A Otterson; Miguel A Villalona-Calero; Sunil Sharma; Mark G Kris; Anthony Imondi; Mirjam Gerber; Dorothy A White; Mark J Ratain; Joan H Schiller; Alan Sandler; Michael Kraut; Sridhar Mani; John R Murren
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

7.  Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.

Authors:  Amber A McBride; Dominique N Price; Loreen R Lamoureux; Alaa A Elmaoued; Jose M Vargas; Natalie L Adolphi; Pavan Muttil
Journal:  Mol Pharm       Date:  2013-09-12       Impact factor: 4.939

8.  Targeted delivery of magnetic aerosol droplets to the lung.

Authors:  Petra Dames; Bernhard Gleich; Andreas Flemmer; Kerstin Hajek; Nicole Seidl; Frank Wiekhorst; Dietmar Eberbeck; Iris Bittmann; Christian Bergemann; Thomas Weyh; Lutz Trahms; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Nanotechnol       Date:  2007-07-22       Impact factor: 39.213

Review 9.  Novel approaches to vaccine delivery.

Authors:  Derek T O'Hagan; Rino Rappuoli
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 10.  Drug delivery and nanoparticles:applications and hazards.

Authors:  Wim H De Jong; Paul J A Borm
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.